J0883
J0883 – Injection, argatroban, 1 mg (for non-esrd use) · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 15 NDCs crosswalked per 1 MG $0.864/unit ASP+6%
📋 J0883 summary
J0883 is a HCPCS Level II J-code used to bill argatroban, 1 mg (for non-esrd use), billed per 1 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J0883: Argatroban-0.9% Nacl*, Argatroban
Code J0883
Billing unit 1 MG Payment limit $0.864/unit NDC-Crosswalk 15
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ0883
DescriptorInjection, argatroban, 1 mg (for non-esrd use)
Billing unit1 MG
Payment limit / unit$0.864
Est. ASP / unit$0.815 est.
Mapped NDCs15
Data periodQ3 2026
Last updated2026-08-20
💊 About Argatroban DRUG GUIDE
Argatroban injection is used to prevent or treat blood clots in adults who have heparin-induced thrombocytopenia (HIT) — a serious condition where the blood thinner heparin causes the body to form dangerous clots instead of preventing them.It is also used as an anticoagulant during percutaneous coronary intervention (PCI) — a procedure to open blocked heart arteries — in adults who have HIT or are at risk for it.
Clinical overview from our editorial drug guide for Argatroban. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.864
Est. ASP / unit
$0.815 est.
Est. after 2% sequester
$0.847
HCPCS dosage
1 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, argatroban, 1 mg (for non-esrd use)
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service9 — Other medical items or services
BETOS-2O1E
ASC payment groupYY
Action codeN — No maintenance this year
Effective date2017-01-01
Date added2017-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J0883 = 1 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J0883 WITH EST. MEDICARE PAY
15 NDCs map to J0883. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.864/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00143-9377-01 | Argatroban 50 mg/50mL INJECTION | Hikma | 1 VIAL in 1 CARTON (0143-9377-01) / 50 mL... | 50 mg/50mL | 50 | $43.20 | — | ● Active | CMS + PDAC |
| 00143-9559-01 | Argatroban 50 mg/50mL INJECTION | Hikma | 1 VIAL in 1 CARTON (0143-9559-01) / 50 mL... | 50 mg/50mL | 50 | $43.20 | — | ● Active | CMS + PDAC |
| 00143-9674-01 | Argatroban 250 mg/2.5mL INJECTION | Hikma | 2.5 mL in 1 VIAL (0143-9674-01) | 250 mg/2.5mL | 250 | $216.00 | — | ● Active | CMS ASP |
| 00409-1140-01 | Argatroban | Pfizer | — | — | 250 | $216.00 | — | — | CMS + PDAC |
| 25021-0414-50 | Argatroban 1 mg/mL INJECTION, SOLUTION | Sagent | 1 VIAL in 1 CARTON (25021-414-50) / 50 mL... | 1 mg/mL | 50 | $43.20 | — | ● Active | CMS + PDAC |
| 42023-0182-01 | Argatroban 250 mg/2.5mL INJECTION | Par | 1 VIAL in 1 CARTON (42023-182-01) / 2.5 m... | 250 mg/2.5mL | 250 | $216.00 | — | ● Active | CMS ASP |
| 42023-0182-89 | Argatroban 250 mg/2.5mL INJECTION | Par | 1 VIAL in 1 CARTON (42023-182-89) / 2.5 m... | 250 mg/2.5mL | 250 | $216.00 | — | ● Active | CMS + PDAC |
| 65145-0126-01 | ARGATROBAN 50 mg/50mL INJECTION | Caplin | 1 VIAL in 1 CARTON (65145-126-01) / 50 mL... | 50 mg/50mL | 50 | $43.20 | — | ● Active | CMS ASP |
| 65219-0429-50 | Argatroban 50 mg/50mL INJECTION | Fresenius | 1 VIAL in 1 CARTON (65219-429-50) / 50 mL... | 50 mg/50mL | 50 | $43.20 | — | ● Active | CMS + PDAC |
| 67457-0212-02 | Argatroban 250 mg/2.5mL INJECTION, SOLUTION | Mylan | 1 VIAL, GLASS in 1 CARTON (67457-212-02)... | 250 mg/2.5mL | 250 | $216.00 | — | ● Active | CMS + PDAC |
| 83301-0062-01 | Argatroban 50 mg/50mL INJECTION | Mullan | 1 VIAL, SINGLE-DOSE in 1 CARTON (83301-006... | 50 mg/50mL | 50 | $43.20 | — | ● Active | CMS ASP |
| 16729-0430-11 | ARGATROBAN 1 mg/mL INJECTION | Accord | 1 VIAL, SINGLE-USE in 1 CARTON (16729-430-... | 1 mg/mL | 1 | $0.86 | — | ● Active | PDAC |
| 16729-0430-43 | ARGATROBAN 1 mg/mL INJECTION | Accord | 10 VIAL, SINGLE-USE in 1 CARTON (16729-430... | 1 mg/mL | 1 | $0.86 | — | ● Active | PDAC |
| 55150-0241-10 | Argatroban 50 mg/50mL INJECTION, SOLUTION | Eugia | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-24... | 50 mg/50mL | 1 | $0.86 | — | ● Active | PDAC |
| 00078-0930-61 | ARGATROBAN (SINGLE USE VIAL,PF) 100 MG/1 ML | Unknown | — | — | 100 | $86.40 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$6.7K
Claims
11
Beneficiaries
—
Spend / beneficiary
—
Spend / claim
$607.47
Trend by period
Where J0883 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #698 of 824
#693
MORPHINE SULFATE(J22... J2270
$8.2K
#694
BUPIVACAINE HCL* J0665
$8.1K
#695
MIDAZOLAM HCL J2250
$8K
#696
PFIZER COVID (6M-4... 91318
$7.4K
#697
BORTEZOMIB(J9049) J9049
$6.9K
#698
ARGATROBAN-0.9% NACL... J0883
$6.7K
#699
DIHYDROERGOTAMINE ME... J1110
$6.5K
#700
PROGRAF(J7525)* J7525
$6.4K
#701
IBANDRONATE SODIUM J1740
$6.3K
#702
LEVOLEUCOVORIN CALCI... J0641
$6.2K
#703
PREMARIN J1410
$6.2K
Total claims — #822 of 824
#814
PELLOGRAFT, PER SQ C... Q4320
13
#815
RETACRIT(Q5105) Q5105
13
#816
ACETAMINOPHEN(J0134) J0134
12
#817
POSACONAZOLE J1837
12
#818
HYMPAVZI PEN J7172
12
#819
DERMACYTE AMN MEM AL... Q4248
12
#820
ORION, PER SQ CM** Q4276
12
#821
DERMACYTE AC MATRX P... Q4343
12
#822
ARGATROBAN-0.9% NACL... J0883
11
#823
NOVACHOR 1 SQ CM** Q4194
11
#824
ESANO ACA, PER SQ CM... Q4275
11
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $6.7K | — | 11 | — | $607.47 |
| 2025 (Q1-Q4) | $34.9K | 17 | 28 | $2,055.18 | $1,247.79 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$13.30
Medicare paid
$10.43
Submitted services
44
Denial rate
68.2%
Allowed / service
$0.95
Submitted charges
$1.5K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
📊 What bills under J0883
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
15 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J0883 billing FAQ
What is HCPCS code J0883?
J0883 is a HCPCS Level II J-code used to bill Injection, argatroban, 1 mg (for non-esrd use) under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J0883?
One unit of J0883 represents 1 MG. Report the number of units equal to the dose administered divided by 1 MG.
How many units of J0883 should I bill?
Divide the dose administered by the code's unit size (1 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J0883?
The Medicare Part B payment limit is $0.864 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.847 per unit. Payment limits are revised quarterly.
Which NDCs bill under J0883?
15 NDCs currently map to J0883 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J0883 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.